Genomic & Biopharma NewsChina is narrowing the U.S. lead in cancer research
China is narrowing the U.S. lead in cancer research phil Wed, 12/07/2016 - 03:31
|Fierce Biotech, 2016-12-07 08:31:35|
Mount Sinai introduces first-ever Coursera course on HPV-associated oral and throat cancer
Mount Sinai's Departments of Academic Informatics and Technology and Otolaryngology - Head and Neck Surgery, in conjunction with the Office of Continuing Medical Education at the Icahn School of Medicine at Mount Sinai, have launched the first-ever Coursera course on HPV-associated oral and throat cancer.
|News Medical Life Sciences, 2016-12-07 07:44:14|
Lung cancer surgery survival rates on the rise
Survival rates following lung cancer surgery are continuing to rise as the number of operations to treat the disease increases, finds a new report published by the Royal College of Physicians (RCP) and the Society for Cardiothoracic Surgery in Great Britain and Ireland (SCTS).
|PharmaTimes, 2016-12-07 06:52:19|
Higher maternal age of successful child bearing may be marker of healthy aging
Death and taxes have long been said to be the only two things guaranteed in life. Exactly when someone will die, in most instances, remains a mystery.
|News Medical Life Sciences, 2016-12-07 06:45:04|
US expands scope of Avastin in ovarian cancer
The US Food and Drug Administration has approved Roche-group Genentech's application to market Avastin for patients with a specific type of ovarian cancer.
|PharmaTimes, 2016-12-07 06:34:20|
EU green light for BMS’ Opdivo in blood cancer
EU regulators have issued a green light for the use of Bristol-Myers Squibb's Opdivo to treat the rare and often aggressive blood cancer classical Hodgkin lymphoma (cHL).
|PharmaTimes, 2016-12-07 06:33:38|
Persistence of job insecurity linked to greater psychological distress in later life
The long-term threat of getting a pink slip is giving some older workers the blues.
|News Medical Life Sciences, 2016-12-07 06:31:59|
AZ’ Tagrisso beats chemo in lung cancer trial
Late-stage data show that AstraZeneca's Tagrisso extended the time lung cancer patients carrying a particular mutation lived without their disease worsening, potentially signalling a new standard of care in the second-line setting.
|PharmaTimes, 2016-12-07 06:31:47|
Controlled Splicing Extends Life Span in Roundworms
Increasing the expression of an RNA splicing factor mimics dietary restriction, prolonging life in nematodes.
|The Scientist, 2016-12-07 05:00:00|